Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Cognitive Dysfunction

Cognition and Cognitive Testing

As noted above, the diagnoses of mild cognitive impairment and dementia of the Alzheimer type both require the presence of memory impairment. To distinguish between MCI and DAT, it is important to determine the degree and course of memory impairment, the presence or absence of additional domains of cognitive dysfunction, and the impact of… Cognition and Cognitive Testing   



Nutritional intervention helps in mild Alzheimer’s disease

A second clinical trial of the medical food Souvenaid confirmed that daily intake of the nutritional intervention improves memory in people with mild Alzheimer’s disease (AD). Results of the trial - called Souvenir II - were presented at the 4th International Conference on Clinical Trials in Alzheimer’s Disease (CTAD) in San Diego, California on… Nutritional intervention helps in mild Alzheimer’s disease   



No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   



New mouse model could revolutionize research in Alzheimer’s disease

Alzheimer’s disease, the primary cause of dementia in the elderly, imposes a tremendous social and economic burden on modern society. In Japan, the burden of the disease in 2050 is estimated to be a half a trillion US dollars, a figure equivalent to the government’s annual revenues.

Unfortunately, it has proven very difficult to… New mouse model could revolutionize research in Alzheimer’s disease   



Living with Dementia

apoplectic dementia1 - genomic dna1 - cause tuberculosis1 - slower overall movement1 - amyloid-β1 - amylin deposition1 - apraxia3 - reconceptualization1 - deep-brain stimulation3 - olanzapine1 - congestive heart failure1 - risk of stroke1 - good sleep habits1 - visual hallucinations1 - inheritable dominant disease1 - risperidone2 - against alzheimer's1 - national alzheimer's project act1 - neurodegenerative diseases1 - blood markers1 - amentia2 - mild alzheimer's stage1 - alzheimer drug1 - signs of parkinson's1 - dementia resistant1 - lipitor1 - beta amyloid protein1 - cancer1 - neurotrophic factor1 - treat parkinson's1 -